View in EDS

Anti-angiogenic therapies in cancer: achievements and open questions.

Saved in:
Bibliographic Details
Title: Anti-angiogenic therapies in cancer: achievements and open questions.
Authors: Ruegg C; Division of Experimental Oncology, Centre Pluridisciplinaire d'Oncologie (CePO), and Swiss Institute for Experimental Cancer Research (ISREC), NCCR molecular Oncology, Chemin des Boveresses, CH-1066 Epalinges, Switzerland. curzio.ruegg@isrec.ch, Mutter N
Source: Bulletin du cancer [Bull Cancer] 2007 Sep; Vol. 94 (9), pp. 753-62.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
Journal Info: Publisher: Elsevier Country of Publication: France NLM ID: 0072416 Publication Model: Print Cited Medium: Internet ISSN: 1769-6917 (Electronic) Linking ISSN: 00074551 NLM ISO Abbreviation: Bull Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 17878094
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Anti-angiogenic therapies in cancer: achievements and open questions.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Ruegg+C%22">Ruegg C</searchLink>; Division of Experimental Oncology, Centre Pluridisciplinaire d'Oncologie (CePO), and Swiss Institute for Experimental Cancer Research (ISREC), NCCR molecular Oncology, Chemin des Boveresses, CH-1066 Epalinges, Switzerland. curzio.ruegg@isrec.ch<br /><searchLink fieldCode="AU" term="%22Mutter+N%22">Mutter N</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220072416%22">Bulletin du cancer</searchLink> [Bull Cancer] 2007 Sep; Vol. 94 (9), pp. 753-62.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't; Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>France <i>NLM ID: </i>0072416 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1769-6917 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200074551%22">00074551 </searchLink><i>NLM ISO Abbreviation: </i>Bull Cancer <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=17878094
RecordInfo BibRecord:
  BibEntity:
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 753
    Titles:
      – TitleFull: Anti-angiogenic therapies in cancer: achievements and open questions.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Ruegg C
      – PersonEntity:
          Name:
            NameFull: Mutter N
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 09
              Text: 2007 Sep
              Type: published
              Y: 2007
          Identifiers:
            – Type: issn-electronic
              Value: 1769-6917
          Numbering:
            – Type: volume
              Value: 94
            – Type: issue
              Value: 9
          Titles:
            – TitleFull: Bulletin du cancer
              Type: main
ResultId 1